GlaxoSmithKline, the Pharmaceutical giant, has given a big boost to Mahindra Satyam, the new name for Satyam, by awarding the outsourcer a five-year support contract.
Under the terms of the multi-million pound deal, Mahindra Satyam will deliver support to GSK’s provide SAP and other critical systems around the world.
Bill Louv, GSK Chief Information Officer said, "GSK is delighted to be able to extend our contract for another 5 years. We look forward to continuing to receive the high level of professionalism and commitment from Satyam and its associates that we have experienced over the past 7 years."
In January Satyam and its customers were rocked by revelations that the outsourcer’s chairman B. Ramalinga Raju, had systematically inflated the company’s earnings
The company was subsequently rescued by the Indian government and put up for sale. Tech Mahindra, the outsourcing arm of India's Mahindra Group, is now going through a complex process to take over the Satyam.
Commenting on the GSK contract, CP Gurnani, CEO of Mahindra Satyam said, “This is a reflection of the fact that we are well on our way to regain our position as a market leader and we are thankful to GSK for having reposed their faith in us.”
Now read Satyam fraud: How it happened